Metraipolis › archive › dc_303d01e57da0
Adjuvant treatment preferences in high-risk upper tract urothelial carcinoma: the perspective of Portuguese medical oncologists — Europe PMC PMID:41165591
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41165591
- DOI
- 10.1093/oncolo/oyaf365
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T21:06:43.994Z
- SHA-256 of the archived text
c976b980f78d7a85cd3f0385a03e7021449e77c5a7244899c48831b40f0fa02e- Stable URL of this page
https://metraipolis.com/documento/dc_303d01e57da0
How to cite
Adjuvant treatment preferences in high-risk upper tract urothelial carcinoma: the perspective of Portuguese medical oncologists — Europe PMC PMID:41165591 — Europe PMC (en), https://europepmc.org/article/MED/41165591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_303d01e57da0 (Metraipolis archive dc_303d01e57da0, sha256 c976b980f78d7a85cd3f0385a03e7021449e77c5a7244899c48831b40f0fa02e)
BibTeX
@misc{dc303d01e57da0,
title = {Adjuvant treatment preferences in high-risk upper tract urothelial carcinoma: the perspective of Portuguese medical oncologists — Europe PMC PMID:41165591},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41165591},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_303d01e57da0; sha256 c976b980f78d7a85cd3f0385a03e7021449e77c5a7244899c48831b40f0fa02e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41165591. Agents can read the archived copy with the MCP tool read_document.